Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-15-083327

Options or other derivatives

  • SVP, Chief Medical Officer acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Senderowicz Adrian · SVP, Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-09-04 Grant or award : show line 1 in the form Incentive Stock Option (right to buy) +135,000 135,000 D
Loading xslF345X03/doc4.xml…